PDPL.NS
Price:
$2.9
Market Cap:
$101.08M
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-08-19
Stock Exchange
NSE
Ticker
PDPL.NS
According to Parenteral Drugs (India) Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.17B. This represents a change of 100.80% compared to the average of 584.20M of the last 4 quarters.
The mean historical Enterprise Value of Parenteral Drugs (India) Ltd. over the last ten years is 7.25B. The current 1.17B Enterprise Value has changed 1.52% with respect to the historical average. Over the past ten years (40 quarters), PDPL.NS's Enterprise Value was at its highest in in the March 2021 quarter at 10.81B. The Enterprise Value was at its lowest in in the June 2012 quarter at 0.
Average
7.25B
Median
7.50B
Minimum
1.18B
Maximum
10.81B
Discovering the peaks and valleys of Parenteral Drugs (India) Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 34.26%
Maximum Annual Enterprise Value = 10.81B
Minimum Annual Increase = -89.09%
Minimum Annual Enterprise Value = 1.18B
| Year | Enterprise Value | Change |
|---|---|---|
| 2022 | 1.18B | -89.09% |
| 2021 | 10.81B | 13.33% |
| 2020 | 9.54B | 10.42% |
| 2019 | 8.64B | -0.99% |
| 2018 | 8.72B | 19.58% |
| 2017 | 7.30B | -5.23% |
| 2016 | 7.70B | 34.26% |
| 2015 | 5.73B | -2.01% |
| 2014 | 5.85B | -16.93% |
| 2013 | 7.04B | 11.01% |
The current Enterprise Value of Parenteral Drugs (India) Ltd. (PDPL.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.18B
5-year avg
7.78B
10-year avg
7.25B
Parenteral Drugs (India) Ltd.’s Enterprise Value is greater than Ganga Pharmaceuticals Limited (80.24M), greater than Ortin Laboratories Limited (159.91M), greater than Fabino Enterprises Ltd (63.77M), greater than Bafna Pharmaceuticals Limited (393.64M), less than Vivimed Labs Ltd. (4.17B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 80.24M | $69.05M | |
| 159.91M | $165.31M | |
| 63.77M | $48.30M | |
| 393.64M | $242.50M | |
| 4.17B | $410.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Parenteral Drugs (India) Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Parenteral Drugs (India) Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Parenteral Drugs (India) Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Parenteral Drugs (India) Ltd. (PDPL.NS)?
What is the 3-year average Enterprise Value for Parenteral Drugs (India) Ltd. (PDPL.NS)?
What is the 5-year average Enterprise Value for Parenteral Drugs (India) Ltd. (PDPL.NS)?
How does the current Enterprise Value for Parenteral Drugs (India) Ltd. (PDPL.NS) compare to its historical average?